Regulation of collagen linearization during cancer progression and metastasis
癌症进展和转移过程中胶原蛋白线性化的调节
基本信息
- 批准号:10310950
- 负责人:
- 金额:$ 12.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-20 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:ArchitectureBiological AssayCellsCessation of lifeClinicalCollagenCollagen FiberEventExtracellular MatrixExtracellular Matrix ProteinsFluorescenceGenerationsIn VitroMalignant NeoplasmsMammary NeoplasmsMechanicsMicroscopyModalityMolecularNeoplasm MetastasisPathogenicityPlayProcessPrognosisRegulationRoleScanning Electron MicroscopyTestingTherapeuticTumor Cell InvasionWISP1 geneaggressive breast cancerbreast cancer progressioncancer cellin vivoinnovationmechanical forcemouse modelneoplastic cellnovelpreventprognostic valuesecond harmonictherapeutic evaluationtumortumor microenvironmenttumor progression
项目摘要
PROJECT SUMMARY
Metastasis accounts for the vast majority of cancer-related deaths but its underlying mechanisms are
incompletely understood. During tumor progression extensive remodeling of the tumor microenvironment
occurs and facilitates metastasis. In particular, linearization of collagen, one of the most abundant extracellular
matrix (ECM) proteins in tumors, is recognized as a hallmark of aggressive breast cancers and is associated
with poor prognosis. At the cellular level, bundles of linearized collagen facilitate tumor cell invasion and
metastasis by providing tracks on which tumor cells can easily migrate. Cell-generated mechanical tension has
been proposed to contribute to collagen remodeling, but it remained unknown whether this is the sole
mechanism by which collagen linearization is established or whether other mechanisms also play prominent
roles in this process. Our recent studies revealed that cancer cells secrete factors that can linearize collagen
independently of cell-generated mechanical forces. Specifically, we found that the tumor cell-secreted factor
WISP1 (CCN4) promotes collagen linearization, tumor cell invasion and metastasis. However, the cellular and
molecular mechanisms by which WISP1 linearizes collagen and promote metastasis remain incompletely
understood. To uncover these mechanisms we will 1) define the specific steps of the metastatic cascade that
are impacted by WISP1, 2) determine the molecular mechanisms by which WISP1 regulates collagen
linearization and promotes tumor cell invasion, and 3) test therapeutic modalities to block WISP1’s function
and prevent metastasis. This will be achieved by performing detailed analyses of breast cancer progression
and metastasis in mouse models and in vitro invasion assays. Central to our studies is also the use of
scanning electron microscopy and intravital multiphoton fluorescence and second harmonic generation
microscopy to visualize alterations in ECM architecture in vitro and in vivo. Globally, these studies will elucidate
fundamental mechanisms of collagen fiber linearization and test innovative therapeutic approaches to limit
metastasis by normalizing collagen architecture.
项目摘要
转移占癌症相关死亡的绝大多数,但其潜在机制是
不完全理解。在肿瘤进展过程中,肿瘤微环境的广泛重塑
发生并促进转移。特别是,胶原蛋白的线性化,胶原蛋白是最丰富的细胞外基质之一,
肿瘤中的细胞外基质(ECM)蛋白被认为是侵袭性乳腺癌的标志,
预后不佳。在细胞水平,成束的线性胶原蛋白促进肿瘤细胞侵袭,
通过提供肿瘤细胞可以容易地迁移的轨道来转移。细胞产生的机械张力
已经提出有助于胶原蛋白重塑,但仍不清楚这是否是唯一的
建立胶原线性化的机制或其他机制是否也起重要作用
在这个过程中的角色。我们最近的研究表明癌细胞分泌的因子可以使胶原蛋白线性化
独立于细胞产生的机械力。具体来说,我们发现肿瘤细胞分泌的因子
WISP 1(CCN 4)促进胶原蛋白线性化、肿瘤细胞侵袭和转移。然而,细胞和
WISP1使胶原线性化并促进转移的分子机制仍不完全
明白为了揭示这些机制,我们将1)定义转移级联的具体步骤,
受WISP 1影响,2)确定WISP 1调节胶原蛋白的分子机制
线性化并促进肿瘤细胞侵袭,以及3)测试治疗方式以阻断WISP1的功能
并防止转移。这将通过对乳腺癌进展进行详细分析来实现
和转移的研究以及体外侵袭测定。我们研究的中心也是使用
扫描电子显微镜和活体多光子荧光和二次谐波产生
通过显微镜观察体外和体内ECM结构的改变。在全球范围内,这些研究将阐明
胶原纤维线性化的基本机制,并测试创新的治疗方法,以限制
通过使胶原结构正常化来转移。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Myriam Labelle其他文献
Myriam Labelle的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Myriam Labelle', 18)}}的其他基金
Regulation of collagen linearization during cancer progression and metastasis
癌症进展和转移过程中胶原蛋白线性化的调节
- 批准号:
10524153 - 财政年份:2020
- 资助金额:
$ 12.54万 - 项目类别:
Regulation of collagen linearization during cancer progression and metastasis
癌症进展和转移过程中胶原蛋白线性化的调节
- 批准号:
10600821 - 财政年份:2020
- 资助金额:
$ 12.54万 - 项目类别:
Regulation of collagen linearization during cancer progression and metastasis
癌症进展和转移过程中胶原蛋白线性化的调节
- 批准号:
10737930 - 财政年份:2020
- 资助金额:
$ 12.54万 - 项目类别:
Regulation of collagen linearization during cancer progression and metastasis
癌症进展和转移过程中胶原蛋白线性化的调节
- 批准号:
10219801 - 财政年份:2020
- 资助金额:
$ 12.54万 - 项目类别:
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 12.54万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 12.54万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 12.54万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 12.54万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 12.54万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 12.54万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 12.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 12.54万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 12.54万 - 项目类别:
Postdoctoral Fellowships